Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis
暂无分享,去创建一个
[1] A. Green,et al. Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[2] K. Trinkaus,et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis , 2009, Neurology.
[3] 松岡 健. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese , 2009 .
[4] A. Vincent,et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica , 2008, Brain : a journal of neurology.
[5] M. Pless. NMO-IgG Predicts Outcome of Recurrent Optic Neuritis , 2008 .
[6] Aaron E Miller,et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. , 2008, Archives of neurology.
[7] D. Kerr,et al. Neuromyelitis optica pathogenesis and aquaporin 4 , 2008 .
[8] S. Pittock,et al. Neuromyelitis Optica: A New Perspective , 2008, Seminars in neurology.
[9] B. Weinshenker,et al. The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.
[10] Y. Itoyama,et al. Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis , 2007, Multiple sclerosis.
[11] F. Mihara,et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. , 2007, Brain : a journal of neurology.
[12] Y. Itoyama,et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. , 2007, Brain : a journal of neurology.
[13] J. Parisi,et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. , 2007, Brain : a journal of neurology.
[14] Y. Itoyama,et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. , 2007, Brain : a journal of neurology.
[15] S. Olindo,et al. Natural history of the visual impairment of relapsing neuromyelitis optica. , 2007, Ophthalmology.
[16] P. Vermersch,et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica , 2007, Multiple sclerosis.
[17] Y. Itoyama,et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica , 2007, Multiple sclerosis.
[18] Y. Itoyama,et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. , 2006, The Tohoku journal of experimental medicine.
[19] B. Weinshenker,et al. Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.
[20] E. Waubant,et al. An open label study of the effects of rituximab in neuromyelitis optica , 2005, Neurology.
[21] D. Zee,et al. The neuro-ophthalmology of multiple sclerosis , 2005, The Lancet Neurology.
[22] Ichiro Nakashima,et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.
[23] T. Lesnick,et al. The natural history of recurrent optic neuritis. , 2004, Archives of neurology.
[24] H. Grossniklaus. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Luchinetti CF,∗ Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuck D, Parisi JE, Lassman H. Brain 2002;125:1450–1461 , 2002 .
[25] Hans Lassmann,et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. , 2002, Brain : a journal of neurology.
[26] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[27] F. Vanderwerf,et al. Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head. , 2001, Investigative ophthalmology & visual science.
[28] P C O'Brien,et al. The clinical course of neuromyelitis optica (Devic’s syndrome) , 1999, Neurology.
[29] E. Nagelhus,et al. Aquaporin-4 Water Channel Protein in the Rat Retina and Optic Nerve: Polarized Expression in Müller Cells and Fibrous Astrocytes , 1998, The Journal of Neuroscience.
[30] G. Kommerell,et al. Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features , 1998, Graefe's Archive for Clinical and Experimental Ophthalmology.
[31] L. Levin,et al. Neural network differentiation of optic neuritis and anterior ischaemic optic neuropathy. , 1996, The British journal of ophthalmology.
[32] R. Mandler,et al. Devic's neuromyelitis optica: A clinicopathological study of 8 patients , 1993, Annals of neurology.
[33] J. Guy,et al. Acute and chronic experimental optic neuritis. Alteration in the blood-optic nerve barrier. , 1984, Archives of ophthalmology.
[34] H. Powell,et al. Pathology of multiple sclerosis. , 1983, Neurologic clinics.
[35] W. Shields,et al. Seizures in Childhood , 1981 .